Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
If developed commercially, the simple test could help PrEP providers monitor adherence and provide support if necessary.
This success is a major advance for vaccine research and may open the door for other important discoveries aiding vaccine and PrEP research.
Project PrEPPY is a pilot study for men who have sex with men and for transgender women. Results could inform future policy.
Project SWERVE was developed for sexual and gender minority youth who use alcohol, tobacco and/or drugs.
The science behind Truvada as pre-exposure prophylaxis reveals an awesome tool that is apparently already helping shrink U.S. HIV rates.
If you’re in rural Iowa, you can use TelePrEP to access the HIV prevention pill.
Researchers added more power to the vaccine that showed modest protection against humans in Thailand in 2009.
But the lease is up on “the first hip-hop monument of Atlanta.”
PrePex is making nonsurgical adult male circumcision easier across Africa.
Campbell Foundation grants have been awarded to Florida International University, University of Miami and Broward Health.
Plus: The city becomes the latest to endorse and promote “Undetectable = Untransmittable” (U=U).
But a major study conducted in Washington, DC, and the Bronx did not find such financial incentives improved linkage to care.
However, some experienced stigma from others, including health care providers, for taking PrEP.
Russia has the third-highest number of new HIV infections globally, after South Africa and Nigeria.
Although Truvada as PrEP is not approved for those under 18, it may be prescribed off-label—but many doctors are wary.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.